![](https://be.mit.edu/sites/default/files/styles/faculty_profile__274x274_/public/MIT-Koch-Institute-Belcher-Hammond-Cancer-Vaccine.png?itok=uXQI3ksu)
Putting the STING into cancer immunotherapy
Friday, May 12, 2023
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.